Showing all 7 results

• 
  Experimental

  Bronchogen

  £46.00
  20 mgBatch file pending

  Airway-tissue focus rather than VIP’s defined VPAC-receptor bronchodilatory biology.

  UnavailableAsk about availability
• 
  Experimental

  Cartalax

  £46.00
  20 mgBatch file pending

  Cartilage-cell focus, rather than BPC-157’s broader repair signalling or GHK-Cu’s collagen/copper biology.

  UnavailableAsk about availability
• 
  Experimental

  Endoluten

  £46.00
  20 mgBatch file pending

  Pineal/circadian branding with uncertain composition, distinct from sequence-defined Epithalon.

  UnavailableAsk about availability
• 
  Experimental

  Livagen

  £46.00
  20 mgBatch file pending

  A liver-tissue bioregulator concept rather than a systemic metabolic receptor agonist.

  UnavailableAsk about availability
• 
  Experimental

  Pinealon

  £46.00
  20 mgBatch file pending

  A tissue-bioregulator concept with uncertain targets, unlike receptor-defined Semax or Selank research.

  UnavailableAsk about availability
• 
  Experimental

  Vesugen

  £46.00
  20 mgBatch file pending

  Vascular-tissue focus distinguishes it from mitochondrial or general healthy-ageing peptides.

  UnavailableAsk about availability
• 
  Experimental

  Vilon

  £46.00
  20 mgBatch file pending

  A minimal dipeptide bioregulator, much smaller and less mechanistically defined than thymosin alpha-1.

  UnavailableAsk about availability